Retraction notice to “Protective effects of ghrelin on cisplatin-induced nephrotoxicity in mice” [Peptides 82 (2016) 85–91, (S019697811630122X), (10.1016/j.peptides.2016.06.003)]

Takashi Nojiri, Hiroshi Hosoda, Toru Kimura, Takeshi Tokudome, Koichi Miura, Hiroyuki Takabatake, Mikiya Miyazato, Meinoshin Okumura, Kenji Kangawa

Research output: Contribution to journalComment/debatepeer-review

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Authors. The Authors express that: although main outcome is correct, there are some errors in calculation, statistical analysis, description for sample numbers and data preparation including, using the common control and vehicle group already reported in the other paper. Those experiments were performed at the same time but, we lacked explanation for those condition (Cancer Chemother. Pharmacol. 2015;75:123–9). Taken together, we decided to retract this article due to those errors.

Original languageEnglish
Article number170876
JournalPeptides
Volume157
DOIs
Publication statusPublished - Nov 2022
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Physiology
  • Endocrinology
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Retraction notice to “Protective effects of ghrelin on cisplatin-induced nephrotoxicity in mice” [Peptides 82 (2016) 85–91, (S019697811630122X), (10.1016/j.peptides.2016.06.003)]'. Together they form a unique fingerprint.

Cite this